• 検索結果がありません。

別紙4

N/A
N/A
Protected

Academic year: 2021

シェア "別紙4"

Copied!
7
0
0

読み込み中.... (全文を見る)

全文

(1)

9 別紙4

研究成果の刊行に関する一覧表(平成30年度)

書籍

著者氏名 論文タイトル名 書籍全体の

編集者名 書 籍 名 出版社名 出版地 出版年 ページ なし

雑誌

発表者氏名 論文タイトル名 発表誌名 巻号 ページ 出版年

Galiè N, Channick RN, Frantz RP, Grünig E, Jing ZC, Moiseeva O, Preston IR, Pulido T, Safdar Z, Tamura Y, McLaughlin VV

Risk stratification and medical therapy of pulmonary arterial hypertension.

Eur Respir J.

53(1) pii:

1801889

2018

Tanabe N, Kawakami T, Satoh T, Matsubara H, Nakanishi N, Ogino H, Tamura Y, Tsujino I, Ogawa A, Sakao S, Nishizaki M, Ishida K, Ichimura Y, Yoshida M, Tatsumi K

Balloon pulmonaty angioplasty for chronic thromboembolic

pulmonary hypertension: A systematic review.

Respir Investig.

56(4) 332-341 2018

Tamura Y, Phan C, Tu L, Le Hiress M, Thuillet R, Jutant EM, Fadel E, Savale L, Huertas A, Humbert M, Guignabert C

Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension.

J Clin Invest.

128(5) 1956-1970 2018

Kawasaki T, Chen W, Htwe YM, Tatsumi K, Dudek SM

DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.

Am J Physiol Lung Cell Mol Physiol.

315 L834-845 2018

Abe M, Tsushima K, Sakayori M, Suzuki K, Ikari J, Terada J, Tatsumi K

Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study.

Drug Des Devel Ther.

12 3369-3375 2018

Abe M, Tsushima K, Ikari J, Kawata N, Terada J, Tanabe N, Tatsumi K

Evaluation of the clinical characteristics of

everolimus-induced lung injury and determination of associated risk factors.

Respir Med.

134 6-11 2018

Matsumura T, Tsushima K, Abe M, Suzuki K,

Yamagishi K, Matsumura A, Ichimura Y, Ikari J, Terada J, Tatsumi K

The effects of pirfenidone in patients with an acute exacerbation of interstitial pneumonia.

Clin Respir J.

12 1550-1558 2018

Matsumura T, Terada J, Kinoshita T, Sakurai Y, Yahaba M, Tsushima K, Sakao S, Nagashima K, Ozaki T, Nagase H, Kobayashi Y, Hiwasa T, Tatsumi K

Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): a potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

PLoS One 13 e0195015 2018

(2)

10 Naito A, Sakao S, Lang

IM, Voelkel NF, Jujo T, Ishida K, Sugiura T, Matsumiya G, Yoshino I, Tanabe N, Tatsumi K

Endothelial cells from pulmonary endarterectomy specimens possess a high angiogenic potential and express high levels of hepatocyte growth factor.

BMC Pulm Med

18 197 2018

Ishiwata T, Abe M, Kasai H, Ikari J, Kawata N, Terada J, Sakao S, Tada Y, Tanabe N, Tatsumi K

Safety of diagnostic flexible bronchoscopy in patients with echocardiographic evidence of pulmonary hypertension.

Respir Investig.

57 73-78 2019

Miwa H, Tanabe N, Jujo T, Kato F, Anazawa R, Yamamoto K, Naito A, Kasai H, Nishimura R, Suda R, Sugiura T, Sakao S, Ishida K, Masuda M, Tatsumi K

Long-term outcome of chronic thromboembolic pulmonary hypertension at a single Japanese pulmonary endarterectomy center.

Circ J. 82 1428-1436 2018

Kinoshita T, Yahaba M, Terada J, Matsumura T, Sakurai Y, Nagashima K, Sakao S, Tatsumi K

Impact of arterial stiffness on WatchPAT variables in patients with obstructive sleep apnea.

J Clin Sleep Med.

14 319-325 2018

Katsumata Y, Terada J, Abe M, Suzuki K, Ishiwata T, Ikari J, Takeda Y, Sakaida E, Tsushima K, Tatsumi K

An analysis of the clinical benefit of 37 bronchoalveolar lavage procedures in patients with hematologic disease and pulmonary complications.

Intern Med.

58(8) 1073-1080 2019

Fujimoto K, Ishiwata T, Kasai H, Terada J, Shionoya Y, Ikari J, Kawata N, Tada Y, Tsushima K, Tatsumi K

Identification of factors during bronchoscopy that affect patient reluctance to undergo repeat examination: Questionnaire analysis after initial bronchoscopy.

PLoS One 13 e0208495 2018

Inagaki T, Terada J, Yahaba M, Kawata N, Jujo T, Nagashima K, Sakao S, Tanabe N, Tatsumi K

Heart rate and oxygen saturation change patterns during 6-min walk test in subjects with chronic thromboembolic pulmonary hypertension.

Respir Care

63 573-583 2018

Haga T, Ito K, Sakashita K, Iguchi M, Ono M, Tatsumi K

Risk factors for pneumonia in patients with schizophrenia.

Neuropsyc hopharmac ol Rep.

38 204-209 2018

Haga T, Ito K, Ono M, Maruyama J, Iguchi M, Suzuki H, Hayashi E, Sakashita K, Nagao T, Ikemoto S, Okaniwa A, Kitami M, Inuo E, Tatsumi K

Risk factors for death due to psychiatric hospital-acquired pneumonia.

Intern Med 57 2473-2478 2018

Suzuki T, Carrier EJ, Talati MH, Rathinasabapathy A, Chen X, Nishimura R, Tada Y, Tatsumi K, West J

Isolation and characterization endothelial-to-mesenchymal transition-cells in pulmonary arterial hypertension.

Am J Physiol Lung Cell Mol Physiol.

314 L118-L126 2018

(3)

11 Ogasawara T, Kohashi Y,

Ikari J, Taniguchi T, Tsuruoka N,

Watanabe-Takano H, Fujimura L, Sakamoto A, Hatano M, Hirata H, Fukushima Y, Fukuda T, Kurasawa K, Tatsumi K, Tokuhisa T, Arima M

Allergic TH2 response governed by B-cell lymphoma 6 function in naturally occurring memory phenotype CD4+T cells.

Front Immunol.

9 750 2018

Chai K, Ning X, Nguyễn TTT, Zhong B, Morinaga T, Li Z, Shingyoji M, Tada Y, Tatsumi K, Shimada H, Hiroshima K, Yamaguchi N, Tagawa M

Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced

expression by inhibiting a proteasome activity.

Oncotarget 9 26130-261 43

2018

Ishiwata T, Abe M, Kasai H, Ikari J, Kawata N, Terada J, Sakao S, Tada Y, Tanabe N, Tatsumi K.

Safety of diagnostic flexible bronchoscopy in patients with echocardiographic evidence of pulmonary hypertension.

Respir Investig.

57 73-78 2019

Tanaka N, Jujo T, Sugiura T, Matsuura K, Kobayashi T, Naito A, Shimazu K, Kasai H, Suda R,

Nishimura R, Ikari J, Sakao S, Tanabe N, Matsumiya G, Tatsumi K

Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary

hypertension.

Respir Med Case Rep.

25 112-115 2018

Uehara Y, Kasai H, Nakajima T, Tanabe N, Tatsumi K, Yoshino I

Aspergillus sternomyelitis developed from chronic

pulmonary aspergillosis as a late complication to lobectomy for lung cancer.

Intern Med 57 2991-2994 2018

Shionoya Y, Kasai H, Terada J, Abe M, Takeda Y, Sakaida E, Tanabe N, Tatsumi K

Cytomegalovirus pneumonia with progressive lung volume loss.

Am J Case Rep.

19 1393-1397 2018

Ogawa A, Sakao S, Tanabe N, Matsubara H, Tatsumi K

Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary

hemangiomatosis: A systematic review.

Respir Investig.

57(2) 183-190 2019

Shimomura I, Abe M, Li Y, Tsushima K, Sakao S, Tanabe N, Ikusaka M, Tatsumi K

Pulmonary hypertension exacerbated by nintedanib administration for idiopathic pulmonary fibrosis.

Intern Med 58 965-968 2019

Naito A, Hiwasa T, Tanabe N, Sanada TJ, Sugiura T, Shigeta A, Terada J, Takizawa H, Kashiwado K, Sakao S, Tatsumi K

Elevated levels of autoantibodies against EXD2 and PHAX in the sera of patients with chronic thromboembolic pulmonary hypertension.

PLoS One 14 e0211377 2019

Ikubo Y, Kasai H, Sugiura T, Saito T, Shoji H, Sakao S, Kasahara Y, Tanabe N, Tatsumi K

Pulmonary hypertension that developed during treatment for hepatopulmonary syndrome and pulmonary arteriovenous malformation.

Intern Med Epub ahead of print

2019

(4)

12 Tanimura S, Kato M, Abe

N, Ohira H, Tsujino I, Atsumi T.

Successful treatment of

tocilizumab-resistant large vessel pulmonary arteritis with

infliximab.

Immunol Med.

41(1) 39-42 2018

Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, Ito H, Kuwana M, Matsubara H, Momomura SI, Nishimura M, Ogino H, Satoh T, Shimokawa H,

Yamauchi-Takihara K, Tatsumi K, Ishibashi-Ueda H, Yamada N, Yoshida S, Abe K, Ogawa A, Ogo T, Kasai T, Kataoka M, Kawakami T, Kogaki S, Nakamura M, Nakayama T, Nishizaki M, Sugimura K, Tanabe N, Tsujino I, Yao A, Akasaka T, Ando M, Kimura T, Kuriyama T, Nakanishi N, Nakanishi T, Tsutsui H

Japanese Circulation Society and the Japanese Pulmonary

Circulation and Pulmonary Hypertension Society Joint Working Group. Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017)

Circ J. 83(4) 842-945 2019

Sato K, Ohira H,

Horinouchi T, Nakaya T, Mazaki Y, Sugimoto A, Watanabe T, Tsujino I, Nishimura M

Chinese herbal medicine Qing-Dai-induced pulmonary arterial hypertension in a patient with ulcerative colitis: A case report and experimental investigation.

Respir Me d Case Re p.

26 265-269 2019

Nakaya T, Tsujino I, Ohira H, Sato T, Watanabe T, Oyama-Manabe N, Nishimura M

Amelioration of right ventricular systolic function and stiffness in a patient with idiopathic pulmonary arterial hypertension treated with oral triple combination therapy.

Pulm Circ. 8(2) 204589401 8765350

2018

Nakamura H, Kato M, Nogochi A, Ohira H, Tsujino I, Atsumi T

Efficient detection of pulmonary arterial hypertension using serum haptoglobin level and cardiac MRI in patients with connective tissue diseases: a pilot study.

Clin Exp Rheumatol .

36(2) 345-346 2018

Shoji T, Mizugaki H, Ikezawa Y, Furuta M, Takashima Y, Kikuchi H, Goudarzi H, Asahina H, Kikuchi J, Kikuchi E, Sakakibara-Konishi J, Shinagawa N, Tsujino I, Nishimura M

Successful Application of Edoxaban in the Treatment of Venous Thromboembolism Recurrence in a Patient with Non-small Cell Lung Cancer after Tumor Shrinkage.

Intern Me d.

57(12) 1769-1772 2018

Watanabe H Treatment Selection in Pulmonary Arterial Hypertension:

Phosphodiesterase Type 5 Inhibitors versus Soluble Guanylate Cyclase Stimulator.

Eur Cardiol

13(1) 35-37 2018

Yasuoka H, Shirai Y, Tamura Y, Takeuchi T, Kuwana M

Predictors of Favorable Responses to Immunosuppressive Treatment in Pulmonary Arterial

Hypertension Associated With Connective Tissue Disease.

Circ J. 82(2) 546-554 2018

(5)

13 Asano Y, Jinnin M,

Kawaguchi Y, Kuwana M, Goto D, Sato S, Takehara K, Hatano M, Fujimoto M, Mugii N, Ihn H

Diagnostic criteria, severity classification and guidelines of systemic sclerosis.

J

Dermatol.

45(6) 633-691 2018

Yasuoka H, Tam YY, Okazaki Y, Tamura Y, Matsuo K,

Feghali-Bostwick C, Takeuchi T, Kuwana M

Fra-1 transgenic mouse as a model for systemic sclerosis: a potential role of M2 polarization.

J

Scleroderm a Relat Disord.

Epub ahead of print

Ahn CM, Matsubara H Chronic Thromboembolic Pulmonary Hypertension:

Endovascular Treatment.

Korean Ci

rc J. 49(3) 214-222 2019 Kim NH, Delcroix M, Jais

X, Madani MM, Matsubara H, Mayer E, Ogo T, Tapson VF, Ghofrani HA, Jenkins DP

Chronic thromboembolic pulmonary hypertension.

Eur Respir

J. 53(1) pii: 18019

15 2019

Ejiri K, Ogawa A, Fujii S, Ito H, Matsubara H

Vascular Injury Is a Major Cause of Lung Injury After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Circ Cardi ovasc Inte rv.

11(12) e005884. 2018

Klok FA, Barco S, Konstantinides SV, Dartevelle P, Fadel E, Jenkins D, Kim NH, Madani M, Matsubara H, Mayer E, Pepke-Zaba J, Delcroix M, Lang IM

Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry.

Eur Respir

J. 52(6) pii: 18016

87 2018

Nakamura K, Sakaguchi M, Matsubara H, Akagi S, Sarashina T, Ejiri K, Akazawa K, Kondo M, Nakagawa K, Yoshida M, Miyoshi T, Ogo T, Oto T, Toyooka S, Higashimoto Y, Fukami K, Ito H

Crucial role of RAGE in

inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension.

PLoS One. 13(9) e0203046. 2018

Akagi S, Matsubara H, Nakamura K, Ito H

Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension.

J Cardiol. 72(6) 466-472 2018

Sato S, Ogawa A, Matsubara H

Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension.

Pulm Circ. 8(2) 204589401 8776496. 2018 Ogawa A, Matsubara H After the Dawn - Balloon

Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension.

Circ J. 82(5) 1222-1230 2018

Shimokawahara H, Ogawa A, Mizoguchi H, Yagi H, Ikemiyagi H, Matsubara H

Vessel Stretching Is a Cause of Lumen Enlargement Immediately After Balloon Pulmonary

Angioplasty: Intravascular Ultrasound Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Circ Cardiovasc Interv.

11(4) e006010. 2018

(6)

14 Mihara K, Ogawa A,

Matsubara H, Terao T, Ichikawa Y

Investigation of safety and efficacy of the new more thermostable formulation of Flolan

(epoprostenol) in Japanese patients with pulmonary arterial

hypertension (PAH)-An open-label, single-arm study.

PLoS One. 13(4) e0195195 2018

Ogawa A, Takahashi Y, Matsubara H

Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.

J Cardiol. 72(3) 255-260 2018

Hosokawa K, Abe K, Horimoto K, Yamasaki Y, Nagao M, Tsutsui H

Balloon Pulmonary Angioplasty Relieves Hemodynamic Stress towards Untreated-Side Pulmonary Vasculature and Ameliorates Its Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.

EuroInterv ention

13(17) 2069-2076 2018

Kuebler WM, Nicolls MR, Olschewski A, Abe K, Rabinovitch M, Stewart DJ, Chan SY, Morrell NW, Archer SL, Spiekerkoetter E

A Pro - Con debate: Current Controversies in PAH Pathogenesis at the American Thoracic Society International Meeting in 2017.

Am J Physiol Lung Cell Mol Physiol.

315(4) L502-L516 2018

Yoshida K, Abe K, Tanaka M, Saku K,

Shinoda-Sakamoto M, Ishikawa T, Watanabe T, Oka M, Sunagawa K, Tsutsui H

Inhibition of

TLR9-NF-kB‒Mediated Sterile Inflammation Improves Pressure Overload‒Induced Right Ventricular Dysfunction in Rats.

Cardiovasc Res.

115(3) 658-668 2019

Nishikawa T, Saku K, Kishi T, Tohyama T, Abe K, Oga Y, Arimura T, Sakamoto T, Yoshida K, Sunagawa K, Tsutsui H

Pulmonary arterial input

impedance reflects the mechanical properties of pulmonary arterial remodeling in rats with pulmonary hypertension.

Life Sci. 212 225-232 2018

Yoshida K, Saku K, Kamada K, Abe K, Tanaka-Ishikawa M, Tohyama T, Nishikawa T, Kishi T, Sunagawa K, Tsutsui H

Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension.

JACC Basic Transl Sci.

3(5) 657-671 2018

Kuwabara Y,

Tanaka-Ishikawa M, Abe K, Hirano M, Hirooka Y, Tsutsui H, Sunagawa K, Hirano K

Proteinase-activated Receptor 1 Antagonism Ameliorates Experimental Pulmonary Hypertension.

Cardiovasc Res.

Epub ahead of print

2019

Kawakubo M, Yamasaki Y, Kamitani T, Sagiyama K, Abe K, Hosokawa K, Uabuuchi H, Honda H

Right ventricular area strain with routine cine MRI after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison with 2D feature tracking MRI.

Eur Radiol. in press 2019

Abe K, Hosokawa K, Tsutusi H

Traditional Screening Tool in the Era of Modern Treatment for Chronic Thromboembolic Pulmonary Hypertension.

Int J Cardiol.

280 182-183 2019

佐藤徹 日本における肺高血圧症診療の

歴史 循 環 器 ジ

ャーナル

66(3) 316-323 2018

(7)

15 佐藤徹 難病疾患-肺動脈性肺高血圧症

の新規原因遺伝子同定を含めた 発症機序全容解明研究

杏 林 医 学 会雑誌

494 17-19 2018

佐藤徹、田村雄一、花岡

正幸 Pulmonary Hypertension Update

肺動脈性肺高血圧症と各群にお ける肺高血圧症の境界域の鑑別・

診断ポイント

メディ カル レビュー社

41 10-17 2018

渡邉裕司 PDF阻害薬とSGC刺激薬-特徴

と使い分け、何を根拠に選択す るのか?-

循環器ジ ャーナル

66(3) 411-417 2018

渡邉裕司 特集 肺高血圧症Cutting Edge 循環器ジ ャーナル

66(3) 314-315 2018

渡邉裕司 特集 希少・難治性疾患の診断

と治療の最前線

11.肺動脈性肺高血圧症

PROGRES S IN MEDICIN E

38 1351-1357 2018

桑名正隆 膠原病 循環器ジ

ャーナル 肺高血圧 症 Cutting Edge

66(3) 330-336 2018

相馬桂、八尾厚史 【右心不全を考える】 識る 成人 先天性心疾患における右心不全 にどう対処すべきか

Heart Vie w.

22 36-43 2018

相馬桂、八尾厚史 【循環器領域における新たな分野

-成人先天性心疾患に挑む】 成

人先天性心疾患に合併する肺高 血圧症に挑む 肺高血圧症を合 併する心房中隔欠損症に対する 治療戦略を中心に

ICUとCCU 42 517-523 2018

常盤洋之、相馬桂、齊藤 暁人、稲葉俊郎、牧尚孝、

八尾厚史、石川友一、白 石公、小室一成

幼児期に血流転換術を施行せず 成人した肺高血圧合併DORVに 対する心内修復術の検討

日本成人 先天性心 疾患学会 雑誌

7 154 2018

八尾厚史 【肺高血圧症の診断と治療】 成人 先天性心疾患に合併する肺動脈 性肺高血圧 成人先天性心疾患 に合併する肺動脈性肺高血圧症

日本内科 学会雑誌

107 219-225 2018

八尾厚史 肺高血圧 未修復シャント性肺動 脈性肺高血圧症に対するTreat &

Repairの適用法

日本成人 先天性心 疾患学会 雑誌

7 103 2018

八尾厚史 タイプ別 肺高血圧症診療のポイ ント 肺動脈腫瘍塞栓微小血管症 性肺高血圧症(PTTM-PH)

Pulmonary Hypertens ion Updat e.

4 48-55 2018

八尾厚史 【肺高血圧症Cutting Edge】肺高 血圧症 何が原因か,なぜ原因と なるのか? 心疾患由来の肺高血 圧症

循環器ジ ャーナル

66 338-346 2018

八尾厚史 知っておきたい成人先天性心疾 患の合併症

心臓 50 1059-1063 2018

参照

関連したドキュメント

・ Rainwater under the temporary release standard and having accumulated inside the fences in the contaminated water tank area, was sprinkled on site after eliminating

The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunica- ble chronic diseases: a meta-analysis of

・ Rainwater under the temporary release standard having accumulated inside the fences in the contaminated water tank area, was sprinkled on site after removing radioactive

本審議会では、平成 30 年9月 27 日に「

別紙(2)-1 系統構成について 特定原子力施設 監視・評価検討会 (第23回)資料 再掲・加筆..

○玄委員 そこで、累積頻度 55%と 95%のほうで、それが平均風速で 55%と 95%か、最大 風速での

事業区間の延長約 1.1km のうち、開削及びシールドトンネル構造が延長約 1.0km、擁壁構 造が延長約

黒い、太く示しているところが敷地の区域という形になります。区域としては、中央のほう に A、B 街区、そして北側のほうに C、D、E